MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 3, 2005; DOI: 10.1124/mol.104.009514


0026-895X/05/6704-1206-1213$20.00
Mol Pharmacol 67:1206-1213, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.009514v1
67/4/1206    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lacasa, D.
Right arrow Articles by Issad, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacasa, D.
Right arrow Articles by Issad, T.
Original Article

Interaction of the Insulin Receptor with the Receptor-Like Protein Tyrosine Phosphatases PTP{alpha} and PTP{epsilon} in Living Cells

Danièle Lacasa, Nicolas Boute, and Tarik Issad

Department of Cell Biology, Institut Cochin, Centre National de la Recherche Scientifique Unité Mixte Recherche 8104, Institut National de la Sante et de la Recherche Medicale U567, Université Paris V, Paris, France

Abstract

The interactions between the insulin receptor and the two highly homologous receptor-like protein tyrosine phosphatases (PTPase) PTP{alpha} and PTP{epsilon} were studied in living cells by using bioluminescence resonance energy transfer. In human embryonic kidney 293 cells expressing the insulin receptor fused to luciferase and substrate-trapping mutants of PTP{alpha} or PTP{epsilon} fused to the fluorescent protein Topaz, insulin induces an increase in resonance energy transfer that could be followed in real time in living cells. Insulin effect could be detected at very early time points and was maximal less than 2 min after insulin addition. Bioluminescence resonance energy-transfer saturation experiments indicate that insulin does not stimulate the recruitment of protein tyrosine phosphatase molecules to the insulin receptor but rather induces conformational changes within preassociated insulin receptor/protein tyrosine phosphatase complexes. Physical preassociation of the insulin receptor with these protein tyrosine phosphatases at the plasma membrane, in the absence of insulin, was also demonstrated by chemical cross-linking with a non-cell-permeable agent. These data provide the first evidence that PTP{alpha} and PTP{epsilon} associate with the insulin receptor in the basal state and suggest that these protein tyrosine phosphatases may constitute important negative regulators of the insulin receptor tyrosine kinase activity by acting rapidly at the plasma membrane level.


Received November 22, 2004; accepted January 3, 2005

Address correspondence to: Dr. Tarik Issad, Institut Cochin, Department of Cell Biology, 22 Rue Méchain, 75014 Paris, France. E-mail: issad{at}cochin.inserm.fr




This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Aga-Mizrachi, T. Brutman-Barazani, A. I. Jacob, A. Bak, A. Elson, and S. R. Sampson
Cytosolic Protein Tyrosine Phosphatase-{epsilon} Is a Negative Regulator of Insulin Signaling in Skeletal Muscle
Endocrinology, February 1, 2008; 149(2): 605 - 614.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Sines, S. Granot-Attas, S. Weisman-Welcher, and A. Elson
Association of Tyrosine Phosphatase Epsilon with Microtubules Inhibits Phosphatase Activity and Is Regulated by the Epidermal Growth Factor Receptor
Mol. Cell. Biol., October 15, 2007; 27(20): 7102 - 7112.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Blanquart, C. Gonzalez-Yanes, and T. Issad
Monitoring the Activation State of Insulin/Insulin-Like Growth Factor-1 Hybrid Receptors Using Bioluminescence Resonance Energy Transfer
Mol. Pharmacol., November 1, 2006; 70(5): 1802 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Z. Tiran, A. Peretz, T. Sines, V. Shinder, J. Sap, B. Attali, and A. Elson
Tyrosine Phosphatases {varepsilon} and {alpha} Perform Specific and Overlapping Functions in Regulation of Voltage-gated Potassium Channels in Schwann Cells
Mol. Biol. Cell, October 1, 2006; 17(10): 4330 - 4342.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Nigorikawa, K. Yoshikawa, T. Sasaki, E. Iida, M. Tsukamoto, H. Murakami, T. Maehama, K. Hazeki, and O. Hazeki
A Naphthoquinone Derivative, Shikonin, Has Insulin-Like Actions by Inhibiting Both Phosphatase and Tensin Homolog Deleted on Chromosome 10 and Tyrosine Phosphatases
Mol. Pharmacol., September 1, 2006; 70(3): 1143 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Blanquart, N. Boute, D. Lacasa, and T. Issad
Monitoring the Activation State of the Insulin-Like Growth Factor-1 Receptor and Its Interaction with Protein Tyrosine Phosphatase 1B Using Bioluminescence Resonance Energy Transfer
Mol. Pharmacol., September 1, 2005; 68(3): 885 - 894.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics